Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Altimmune Inc (ALT)

1.82 -0.03 (-1.62%)

01-19 16:00

Open:

1.83

Pre. Close:

1.85

High:

1.84

Low:

1.8

Volume:

95,530

Market Cap:

28M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.843 - 1.856

1.856 - 1.866

Low:

1.766 - 1.784

1.784 - 1.797

Close:

1.796 - 1.819

1.819 - 1.838

Technical analysis  (as of: 2018-01-19 4:23:33 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 2.26     One year: 2.57

Support:

Support1: 1.51    Support2: 1.26

Resistance:

Resistance1: 1.94    Resistance2: 2.20

Pivot:

1.95

Moving Averages:

MA(5): 1.88     MA(20): 1.87

MA(100): 2.19     MA(250): 1.66

MACD:

MACD(12,26):     Signal(12,26,9): 0.01

%K %D:

%K(14,3): 29.40     %D(3): 42.57

RSI:

RSI(14): 43.79

52-Week:

High: 4.59  Low: 0.024  Change(%): 7180.0

Average Vol(K):

3-Month: 22542  10-Days 18298

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ALT has closed below the lower band by 3.1%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for ALT is to continue within current trading range. It is unclear right now based on current numbers. 54.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to ALT's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

15.63

Shares Float (M)

9.03

% Held by Insiders

14.50

% Held by Institutions

1.83

Shares Short (K)

2

Shares Short Prior Month (K)

Stock Financials

EPS

-3.370

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

-2.042

Book Value (p.s.)

3.120

PEG Ratio

Profit Margin

Operating Margin

-169.53

Return on Assets (ttm)

-16.4

Return on Equity (ttm)

-95.2

Qtrly Rev. Growth

409.6

Gross Profit (p.s.)

0.335

Sales Per Share

EBITDA (p.s.)

-0.971

Qtrly Earnings Growth

Operating Cash Flow (M)

-16.90

Levered Free Cash Flow (M)

-15.19

atoplab.com

Valuation

P/E

-0.54

P/E Growth Ratio

-0.02

P/BV

0.58

P/S

40065636.00

P/CF

-1.68

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2017-02-03

Ex-Dividend Date

2017-01-20

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.